Showing results (1891-1900 of 1,899) with videos related to

Sort By:
Pageof 190
You have reached the last page of results.This site can display upto 1,899 results.
Immunotherapy|August 25, 2026
Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case reportZhiqiang Li, Yufei Li, Yuhan Zhang, et al.
Immunotherapy|August 25, 2026
Efficacy of PARP inhibitor and immune checkpoint inhibitor combination therapy in PD-L1-negative cancers: a systematic review and meta-analysisSusu Zhou, Vishw Patel, Noriko Kishi, et al.
Immunotherapy|August 24, 2026
Injection-based safety of aqueous venom immunotherapy during venom extract shortage: impact of forced depot-to-aqueous switchingGökten Bulut, Rukiye Demiralp, Şefika Karabaş, et al.
Immunotherapy|September 16, 2026
Efficacy and safety of chimeric antigen receptor T-cell therapy in primary central nervous system lymphoma: a systematic review and meta-analysisAbdulrahman F Al-Mashdali, Mujahid O Abdelraof, Rasha Kaddoura, et al.
Immunotherapy|September 8, 2026
In vivo CAR-T for solid tumors: facing all the challenges of ex vivo CAR-T and moreYulong Xia, Jintian Song, Jiong Wu
Immunotherapy|October 11, 2026
Baseline circulating immunophenotype as a predictor of immune-related adverse events in NSCLC patients treated with immune checkpoint inhibitorsA Dodi, G Mazzaschi, F Pecci, et al.
Immunotherapy|October 8, 2026
Association of early dynamic changes in peripheral blood immune-inflammatory indices with subsequent acquired resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer: a landmark analysisLin Song, Wanghui Lv, Qingbo Wang, et al.
Immunotherapy|October 28, 2026
The potential of PDHA1 as a cuproptosis-related prognostic and immune biomarker in lung squamous cell carcinomaShaopeng Zheng, Zixun Huang, Geng Wang, et al.
Immunotherapy|November 6, 2026
Nanobodies as next-generation antigen recognition domains for CAR-based cellular immunotherapies in cancerAmirhosein Maali, Shaghayegh Fazelian, Mahdieh Jafari, et al.
Pageof 190